The treatment with D + Q was able to reduce MCP-1 release in normal but not in IPF fibroblast, while SOC drugs showed no effect neither in normal nor IPF senescent fibroblast (Fig. 6c). Here, CCL2 is linked to idiopathic pulmonary fibrosis.